octenidine has been researched along with Malignant Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SB; Chen, XC; Dai, J; Dai, LT; Huang, ZS; Li, WW; Ou, TM; Tan, JH; Tang, GX; Wu, TY | 1 |
Beck, H; Djedovic, G; Koller, R; Matiasek, J; Mattesich, M; Pierer, G; Rieger, UM; Unger, L | 1 |
2 other study(ies) available for octenidine and Malignant Melanoma
Article | Year |
---|---|
Discovery of Clinically Used Octenidine as
Topics: Animals; Cell Line, Tumor; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mice; Mutation; Phosphatidylinositol 3-Kinases; Skin Neoplasms | 2023 |
Outcomes for split-thickness skin transplantation in high-risk patients using octenidine.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents, Local; Diabetes Mellitus, Type 2; Female; Graft Survival; Humans; Imines; Leg; Male; Melanoma; Middle Aged; Necrosis; Negative-Pressure Wound Therapy; Plastic Surgery Procedures; Postoperative Complications; Povidone; Pyridines; Reoperation; Risk Factors; Skin Transplantation; Smoking; Surgical Wound Infection; Treatment Outcome; Wound Healing | 2015 |